Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Sage Therapeutics, Inc.

Report topline data from the KINETIC Phase 2 study of SAGE-324 in ET

Delivered after the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
7 Jan 2021
Due
31 Mar 2021
Delivered
April 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Early 2021: KINETIC (324-ETD-201) Study: The Company expects topline data from the KINETIC Study, a placebo-controlled Phase 2 trial evaluating the safety and efficacy of SAGE-324”

What we found

Evidence strength A What the grades mean

The company reported topline results from the KINETIC study in April 2021, which is after the 'early 2021' deadline.

  • A
    Sage Therapeutics, Inc. 10-K filed 2022-02-24 Regulatory filing · published 24 Feb 2022 · retrieved 24 Oct 2026 · kept permanently by the SEC · fingerprint 7ad4883a20a6
    “In April 2021, we and Biogen reported topline results from our placebo-controlled Phase 2 clinical trial evaluating the safety and efficacy of SAGE-324 for the treatment of essential tremor, known as the KINETIC Study.” ✓ confirmed on the page

Checked 24 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
KINETIC Phase 2 study topline data
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Depends on
Customer

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Sage Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-C597553-021283 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.